紫光國微(002049.SZ):海外銷售收入主要來自於智能安全芯片及石英晶體業務
格隆匯5月23日丨有投資者在投資者互動平台向紫光國微(002049.SZ)提問,“產品海外客户具體銷售哪裏,特種集成電路的客户主要是哪幾家,華為包括在內嗎?製造和封裝封測哪個客户給代加工。對於受種種因素整體影響,股價下跌如此厲害,公司有具體回購股票措施嗎?”
紫光國微(002049.SZ)回覆稱,公司海外銷售收入主要來自於智能安全芯片及石英晶體業務,產品應用領域廣,客户分佈範圍較大。特種集成電路的下游客户為眾多特種領域用户,包括一些科研院所等。芯片製造的代工廠也包括各主要晶圓廠。近期股價調整較多,公司已經啟動回購工作,積極維護股價,具體情況請查閲相關公吿。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.